Brief: Pulse Biosciences Announces Positive Clinical Data On Nano-Pulse Stimulation Procedure For Low-Risk Basal Cell Carcinoma Lesions
06/10/2022 13:40
Oct 6 (Reuters) - Pulse Biosciences Inc PLSE.O :
* PULSE BIOSCIENCES ANNOUNCES POSITIVE CLINICAL DATA ON
NANO-PULSE
STIMULATION PROCEDURE FOR LOW-RISK BASAL CELL CARCINOMA LESIONS
Source text for Eikon: ID:nBwb9yj3pa
Further company coverage: PLSE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Pulse Biosciences
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Pulse Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Pulse Biosciences Q2 net loss widens, cash position strengthens
Pulse Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants